101 related articles for article (PubMed ID: 10097297)
1. [Treatment of mild and moderate hypertension with enalapril (multicenter study of enap and enap N in Ukraine)].
Dziak GV; Kolomiets SN; Minakov AI; Fushteĭ IM; Iavorskiĭ OG; Bekker VF; Vankhanen VN; Davydova IV; Zaĭtseva VI; Kolesnik TV; Kolomiets VV; Svishchenko EP; Taran AI; Shlykova NA; Barbich-Zhagar B
Ter Arkh; 1999; 71(1):31-4. PubMed ID: 10097297
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
Mugellini A; Dobovisek J; Planinc D; Cremonesi G; Fogari R
Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
[TBL] [Abstract][Full Text] [Related]
3. [The treatment of mild and moderate arterial hypertension with enalapril. A multicenter study of enap and enap-HL in Russia].
Ol'binskaia LI
Ter Arkh; 1997; 69(8):86-8. PubMed ID: 9381405
[No Abstract] [Full Text] [Related]
4. [Comparative study of spirapril (quadropril) and amlodipine efficacy. Results of randomized trial in patients with mild to moderate arterial hypertension].
Shal'nova SA; Martsevich SIu; Deev AD; Kutishenko NP; Kukushkin SK; Manoshkina EM; Alimova EV; Semenova IuE; Lebedev AV; Koniakhina IP; Zagrebel'nyĭ AV
Ter Arkh; 2000; 72(10):86-9. PubMed ID: 11220888
[TBL] [Abstract][Full Text] [Related]
5. [Co-renitek treatment of patients with moderate and severe forms of hypertensive disease].
Chazova IE; Ratova LG; Dmitriev VV; Khanbalaeva MN; Kotkina TI
Ter Arkh; 2003; 75(8):21-6. PubMed ID: 14520845
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hypertension in the very old.
Otterstad JE; Ruilope LM
Int J Clin Pract Suppl; 2000 Nov; (114):10-9. PubMed ID: 11221289
[TBL] [Abstract][Full Text] [Related]
7. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Levine B
Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and vascular effects of ACE inhibitor enalapril in combination with thiaside-like diuretic indapamide in hypertensive outpatients. Results of the multicenter trial POEMA].
Belenkov IuN; Ageev FT; Orolova IaA; Abrosimova OIu; Volkova EG; Gapon LI; Katel'nitskaia LI; Kondari AO; Patrusheva IF; Fomin IV; Khokhlov RA
Ter Arkh; 2007; 79(8):33-8. PubMed ID: 17926468
[TBL] [Abstract][Full Text] [Related]
9. Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide.
Guerrero P; Fuchs FD; Moreira LM; Martins VM; Bertoluci C; Fuchs SC; Gus M
Clin Exp Hypertens; 2008 Oct; 30(7):553-64. PubMed ID: 18855259
[TBL] [Abstract][Full Text] [Related]
10. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
Giri S; Mahajan SK; Sen R; Sharma A
J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
[TBL] [Abstract][Full Text] [Related]
11. [Effectiveness and tolerance of fosinopril in the treatment of arterial hypertension of mild and medium severity].
Rosolová H; Cech J; Sefrna F
Vnitr Lek; 2001 Dec; 47(12):834-9. PubMed ID: 11826546
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group.
Karlberg BE; Lins LE; Hermansson K
J Hypertens; 1999 Feb; 17(2):293-302. PubMed ID: 10067800
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
Palmieri V; Devereux RB
Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
[TBL] [Abstract][Full Text] [Related]
14. [Antihypertensive effectiveness of enalapril and hydrochlorothiazide as a combination drug].
Pirich C; Banyai M
Wien Med Wochenschr; 1993; 143(11):290-3. PubMed ID: 8212715
[TBL] [Abstract][Full Text] [Related]
15. [Spirapril - a new long-acting ACE inhibitor: efficacy and safety in patients with arterial hypertension in combination with diabetes mellitus and impaired kidney function].
Iakusevich VV; Mozheĭko ME; Paliutin ShKh; Berezina MIu; Martsevich SIu; Shal'nova SA; Deev AD; Kutishenko NP; Alimova EV; Koniakhina IP; Semenova IuE
Ter Arkh; 2000; 72(10):82-6. PubMed ID: 11220887
[TBL] [Abstract][Full Text] [Related]
16. Enalapril as first choice treatment of mild, moderate and severe essential hypertension: results of an open multicentre clinical trial. New Zealand Hypertension Study Group.
N Z Med J; 1987 Mar; 100(819):137-9. PubMed ID: 2837697
[TBL] [Abstract][Full Text] [Related]
17. [Thiaside diuretics in combination with inhibitors of angiotensin-converting enzyme in patients with diabetes mellitus type 2 comorbid with arterial hypertension].
Chazova IE; Mychka VB; Duishvili DE
Ter Arkh; 2004; 76(8):28-32. PubMed ID: 15471392
[TBL] [Abstract][Full Text] [Related]
18. [Antihypertensive efficacy, tolerance and safety of lisinopril (sinopril) and captopril (capoten) in patients with mild and moderate arterial hypertension].
Ol'binskaia LI; Sizova ZhM; Zheleznykh EA; Fitilev SB; Sergeeva TE; Pukhlianko ME; Potapova GN
Ter Arkh; 1999; 71(11):61-4. PubMed ID: 10626341
[TBL] [Abstract][Full Text] [Related]
19. An open comparative clinical trial to assess the efficacy and safety of losartan versus enalapril in mild to moderate hypertension.
Chowta KN; Chowta MN; Bhat P; Adhikari PM
J Assoc Physicians India; 2002 Oct; 50():1236-9. PubMed ID: 12568205
[TBL] [Abstract][Full Text] [Related]
20. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
